Expedited Review (ER) is designed primarily to provide an expeditious, efficient and inexpensive method of liquidating all claims (except those involving Lung Cancer 2 – Disease Level VI, Foreign Claims, and Indirect Claims) where the claim can be easily verified as meeting presumptive medical and exposure criteria.  The ER method thus provides claimants with a substantially less burdensome process for pursuing claim than does Individual Review.  This process is also intended to provide qualifying claimants with fixed and certain claim payments.